Prelude Therapeutics Inc

PRLD USD0.0001
Create an alert
Sell$4.70
Buy$4.72
$0.14 (2.77%)
Last updated today at
Back to dashboard

Director deals

Listed below are trades carried out by directors and other individuals which are required to be notified to the market.

Recent deals

DateName and position (if held)Deal typeNumber of
shares dealt
Price per
share
Value of
trade
Shares
remaining
21 April 2026
BAKER BROS ADVISORS LPHedge Fund
Buy
Regular purchase transaction
2,137,651$4.44$9,490,956.6720,105,994
21 April 2026
ORBIMED ADVISORS LLCPrivate Equity
Buy
Regular purchase transaction
1,689,189$4.44$7,499,999.1611,808,945
21 April 2026
BAKER BROS ADVISORS LPHedge Fund
Buy
Regular purchase transaction
114,601$4.44$508,816.981,678,273
21 April 2026
ORBIMED ADVISORS LLCPrivate Equity
Buy
Regular purchase transaction
1,126,126$4.44$4,999,999.441,126,126
4 October 2025
Jane Edna HuangPresident
Sell
Tax related
3,355$1.47$4,931.8586,917

End of results. Director deals are only available for the last 12 months.

5 most significant deals

DateName and position (if held)Deal typeNumber of
shares dealt
Price per
share
Value of
trade
Shares
remaining
21 April 2026
BAKER BROS ADVISORS LPHedge Fund
Buy
Regular purchase transaction
2,137,651$4.44$9,490,956.6720,105,994
21 April 2026
ORBIMED ADVISORS LLCPrivate Equity
Buy
Regular purchase transaction
1,689,189$4.44$7,499,999.1611,808,945
21 April 2026
ORBIMED ADVISORS LLCPrivate Equity
Buy
Regular purchase transaction
1,126,126$4.44$4,999,999.441,126,126
21 April 2026
BAKER BROS ADVISORS LPHedge Fund
Buy
Regular purchase transaction
114,601$4.44$508,816.981,678,273
4 October 2025
Jane Edna HuangPresident
Sell
Tax related
3,355$1.47$4,931.8586,917

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Director deal information provided by Factset.